Cargando…

Surgical Management of Inferior Turbinate Hypertrophy in the Era of Widespread Communicable Disease

Inferior turbinate reduction procedures have been performed for decades. After significant evolution, turbinoplasty and other mucosal-sparing techniques have become the main method to successfully reduce turbinate hypertrophy. The debate of which technique produces the most effective and durable out...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Drew H, Daines, Benjamin S, Cazzaniga, Juliana, Bhandarkar, Naveen D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968500/
https://www.ncbi.nlm.nih.gov/pubmed/36855496
http://dx.doi.org/10.7759/cureus.34280
_version_ 1784897517869072384
author Smith, Drew H
Daines, Benjamin S
Cazzaniga, Juliana
Bhandarkar, Naveen D
author_facet Smith, Drew H
Daines, Benjamin S
Cazzaniga, Juliana
Bhandarkar, Naveen D
author_sort Smith, Drew H
collection PubMed
description Inferior turbinate reduction procedures have been performed for decades. After significant evolution, turbinoplasty and other mucosal-sparing techniques have become the main method to successfully reduce turbinate hypertrophy. The debate of which technique produces the most effective and durable outcomes is ongoing. During this critical era of widespread communicable diseases, including but not limited to COVID-19, HIV, and hepatitis, additional attention is necessary to balance outcomes with a degree of generation of airborne particles when selecting a technique. This review article aims to identify the optimal method for inferior turbinate reduction that weighs both outcomes and aerosol production. The MEDLINE database was searched to discover relevant publications through August 2022. Key search terms included inferior turbinate hypertrophy, turbinate reduction surgery, turbinoplasty methods, surgical management of turbinate hypertrophy, surgical aerosol generation, COVID-19 surgery, surgery smoke plume, SARS-CoV-2 transmission during surgery, and nasal procedures COVID-19 aerosols. Surgical management of the inferior turbinates includes radiofrequency ablation (RFA), microdebrider-assisted turbinoplasty (MAIT), electrocautery, laser, and ultrasound. Piezo-assisted turbinoplasty and a turbinate-specific coblation wand are new additions to the literature. All techniques appear to improve patient symptoms of nasal obstruction. MAIT and RFA are comparable, although MAIT demonstrated better long-term outcomes in some studies and appears to generate fewer airborne particles. Studies evaluating the production of aerosols due to RFA are lacking. Ultrasound outcomes are also excellent and generate no aerosols, but the technique has not been compared against the microdebrider. Electrocautery can result in increased pain and crusting for patients and causes the highest amount of aerosols. Deficiencies of current studies, including a lack of comparison of aerosol generation, duration of follow-up, omission of outfracture, and inadequate randomized controlled trials among existing and new techniques, have limited the identification of the best inferior turbinate reduction method. Given the durability of MAIT and its minimal aerosol production, it can be reinforced as the most sensible technique until further evidence is available.
format Online
Article
Text
id pubmed-9968500
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-99685002023-02-27 Surgical Management of Inferior Turbinate Hypertrophy in the Era of Widespread Communicable Disease Smith, Drew H Daines, Benjamin S Cazzaniga, Juliana Bhandarkar, Naveen D Cureus Otolaryngology Inferior turbinate reduction procedures have been performed for decades. After significant evolution, turbinoplasty and other mucosal-sparing techniques have become the main method to successfully reduce turbinate hypertrophy. The debate of which technique produces the most effective and durable outcomes is ongoing. During this critical era of widespread communicable diseases, including but not limited to COVID-19, HIV, and hepatitis, additional attention is necessary to balance outcomes with a degree of generation of airborne particles when selecting a technique. This review article aims to identify the optimal method for inferior turbinate reduction that weighs both outcomes and aerosol production. The MEDLINE database was searched to discover relevant publications through August 2022. Key search terms included inferior turbinate hypertrophy, turbinate reduction surgery, turbinoplasty methods, surgical management of turbinate hypertrophy, surgical aerosol generation, COVID-19 surgery, surgery smoke plume, SARS-CoV-2 transmission during surgery, and nasal procedures COVID-19 aerosols. Surgical management of the inferior turbinates includes radiofrequency ablation (RFA), microdebrider-assisted turbinoplasty (MAIT), electrocautery, laser, and ultrasound. Piezo-assisted turbinoplasty and a turbinate-specific coblation wand are new additions to the literature. All techniques appear to improve patient symptoms of nasal obstruction. MAIT and RFA are comparable, although MAIT demonstrated better long-term outcomes in some studies and appears to generate fewer airborne particles. Studies evaluating the production of aerosols due to RFA are lacking. Ultrasound outcomes are also excellent and generate no aerosols, but the technique has not been compared against the microdebrider. Electrocautery can result in increased pain and crusting for patients and causes the highest amount of aerosols. Deficiencies of current studies, including a lack of comparison of aerosol generation, duration of follow-up, omission of outfracture, and inadequate randomized controlled trials among existing and new techniques, have limited the identification of the best inferior turbinate reduction method. Given the durability of MAIT and its minimal aerosol production, it can be reinforced as the most sensible technique until further evidence is available. Cureus 2023-01-27 /pmc/articles/PMC9968500/ /pubmed/36855496 http://dx.doi.org/10.7759/cureus.34280 Text en Copyright © 2023, Smith et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Otolaryngology
Smith, Drew H
Daines, Benjamin S
Cazzaniga, Juliana
Bhandarkar, Naveen D
Surgical Management of Inferior Turbinate Hypertrophy in the Era of Widespread Communicable Disease
title Surgical Management of Inferior Turbinate Hypertrophy in the Era of Widespread Communicable Disease
title_full Surgical Management of Inferior Turbinate Hypertrophy in the Era of Widespread Communicable Disease
title_fullStr Surgical Management of Inferior Turbinate Hypertrophy in the Era of Widespread Communicable Disease
title_full_unstemmed Surgical Management of Inferior Turbinate Hypertrophy in the Era of Widespread Communicable Disease
title_short Surgical Management of Inferior Turbinate Hypertrophy in the Era of Widespread Communicable Disease
title_sort surgical management of inferior turbinate hypertrophy in the era of widespread communicable disease
topic Otolaryngology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968500/
https://www.ncbi.nlm.nih.gov/pubmed/36855496
http://dx.doi.org/10.7759/cureus.34280
work_keys_str_mv AT smithdrewh surgicalmanagementofinferiorturbinatehypertrophyintheeraofwidespreadcommunicabledisease
AT dainesbenjamins surgicalmanagementofinferiorturbinatehypertrophyintheeraofwidespreadcommunicabledisease
AT cazzanigajuliana surgicalmanagementofinferiorturbinatehypertrophyintheeraofwidespreadcommunicabledisease
AT bhandarkarnaveend surgicalmanagementofinferiorturbinatehypertrophyintheeraofwidespreadcommunicabledisease